Molecular pathology testing for personalized cancer treatment selection

Laboratory analysis of tumor tissue at a molecular level (e.g., DNA, RNA, proteins) to identify specific genetic alterations that can inform treatment decisions, such as targeted therapies or immunotherapies.

Molecular pathology testing plays a crucial role in personalizing cancer treatment. By identifying specific genetic changes within a tumor, clinicians can select therapies most likely to be effective, maximizing treatment response and potentially minimizing side effects.

This phrase is typically used when describing the planned diagnostic workup for a patient with cancer, particularly when considering targeted or personalized treatment options.